Cargando…
Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids
BACKGROUND: Catastrophic errors in healthcare are rare, yet the consequences are so serious that where possible, special procedures are put in place to prevent them. As systems become safer, it becomes progressively more difficult to detect the remaining vulnerabilities. Using inadvertent intratheca...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145437/ https://www.ncbi.nlm.nih.gov/pubmed/24643293 http://dx.doi.org/10.1136/bmjqs-2013-002572 |
_version_ | 1782332177593139200 |
---|---|
author | Franklin, Bryony Dean Panesar, Sukhmeet S Vincent, Charles Donaldson, Liam J |
author_facet | Franklin, Bryony Dean Panesar, Sukhmeet S Vincent, Charles Donaldson, Liam J |
author_sort | Franklin, Bryony Dean |
collection | PubMed |
description | BACKGROUND: Catastrophic errors in healthcare are rare, yet the consequences are so serious that where possible, special procedures are put in place to prevent them. As systems become safer, it becomes progressively more difficult to detect the remaining vulnerabilities. Using inadvertent intrathecal administration of vinca alkaloids as an example, we investigated whether analysis of incident report data describing low-harm events could bridge this gap. METHODS: We studied nine million patient safety incidents reported from England and Wales between November 2003 and May 2013. We searched for reports relating to administration of vinca alkaloids in patients also receiving intrathecal medication, and classified the failures identified against steps in the relevant national protocol. RESULTS: Of 38 reports that met our inclusion criteria, none resulted in actual harm. The stage of the medication process most commonly involved was ‘supply, transport and storage’ (15 cases). Seven cases related to dispensing, six to documentation, and four each to prescribing and administration. Defences most commonly breached related to separation of intravenous vinca alkaloids and intrathecal medication in timing (n=16) and location (n=8); potential for confusion due to inadequate separation of these drugs therefore remains. Problems involved in six cases did not align with the procedural defences in place, some of which represented major hazards. CONCLUSIONS: We identified areas of concern even within the context of a highly controlled standardised national process. If incident reporting systems include and encourage reports of no-harm incidents in addition to actual patient harm, they can facilitate monitoring the resilience of healthcare processes. Patient safety incidents that produce the most serious harm are often rare, and it is difficult to know whether patients are adequately protected. Our approach provides a potential solution. |
format | Online Article Text |
id | pubmed-4145437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-41454372014-09-02 Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids Franklin, Bryony Dean Panesar, Sukhmeet S Vincent, Charles Donaldson, Liam J BMJ Qual Saf Original Research BACKGROUND: Catastrophic errors in healthcare are rare, yet the consequences are so serious that where possible, special procedures are put in place to prevent them. As systems become safer, it becomes progressively more difficult to detect the remaining vulnerabilities. Using inadvertent intrathecal administration of vinca alkaloids as an example, we investigated whether analysis of incident report data describing low-harm events could bridge this gap. METHODS: We studied nine million patient safety incidents reported from England and Wales between November 2003 and May 2013. We searched for reports relating to administration of vinca alkaloids in patients also receiving intrathecal medication, and classified the failures identified against steps in the relevant national protocol. RESULTS: Of 38 reports that met our inclusion criteria, none resulted in actual harm. The stage of the medication process most commonly involved was ‘supply, transport and storage’ (15 cases). Seven cases related to dispensing, six to documentation, and four each to prescribing and administration. Defences most commonly breached related to separation of intravenous vinca alkaloids and intrathecal medication in timing (n=16) and location (n=8); potential for confusion due to inadequate separation of these drugs therefore remains. Problems involved in six cases did not align with the procedural defences in place, some of which represented major hazards. CONCLUSIONS: We identified areas of concern even within the context of a highly controlled standardised national process. If incident reporting systems include and encourage reports of no-harm incidents in addition to actual patient harm, they can facilitate monitoring the resilience of healthcare processes. Patient safety incidents that produce the most serious harm are often rare, and it is difficult to know whether patients are adequately protected. Our approach provides a potential solution. BMJ Publishing Group 2014-09 2014-03-18 /pmc/articles/PMC4145437/ /pubmed/24643293 http://dx.doi.org/10.1136/bmjqs-2013-002572 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Original Research Franklin, Bryony Dean Panesar, Sukhmeet S Vincent, Charles Donaldson, Liam J Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids |
title | Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids |
title_full | Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids |
title_fullStr | Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids |
title_full_unstemmed | Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids |
title_short | Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids |
title_sort | identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145437/ https://www.ncbi.nlm.nih.gov/pubmed/24643293 http://dx.doi.org/10.1136/bmjqs-2013-002572 |
work_keys_str_mv | AT franklinbryonydean identifyingsystemsfailuresinthepathwaytoacatastrophiceventananalysisofnationalincidentreportdatarelatingtovincaalkaloids AT panesarsukhmeets identifyingsystemsfailuresinthepathwaytoacatastrophiceventananalysisofnationalincidentreportdatarelatingtovincaalkaloids AT vincentcharles identifyingsystemsfailuresinthepathwaytoacatastrophiceventananalysisofnationalincidentreportdatarelatingtovincaalkaloids AT donaldsonliamj identifyingsystemsfailuresinthepathwaytoacatastrophiceventananalysisofnationalincidentreportdatarelatingtovincaalkaloids |